

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.92464554 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.92464554 |
| 3 | desmosome organization (GO:0002934) | 3.88281519 |
| 4 | cell-substrate junction assembly (GO:0007044) | 3.67921347 |
| 5 | detection of temperature stimulus (GO:0016048) | 3.61722301 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.51214641 |
| 7 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.42755245 |
| 8 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.40093955 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.36058703 |
| 10 | sodium ion export (GO:0071436) | 3.29802351 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.24732236 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.15130106 |
| 13 | cell communication involved in cardiac conduction (GO:0086065) | 3.03716988 |
| 14 | neurofilament cytoskeleton organization (GO:0060052) | 2.96662915 |
| 15 | proline transport (GO:0015824) | 2.92518175 |
| 16 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.87779997 |
| 17 | membrane repolarization (GO:0086009) | 2.85072091 |
| 18 | protein localization to endosome (GO:0036010) | 2.82332657 |
| 19 | negative regulation of microtubule polymerization (GO:0031115) | 2.79545297 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 2.78634851 |
| 21 | actin filament depolymerization (GO:0030042) | 2.75063149 |
| 22 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.74147086 |
| 23 | signal complex assembly (GO:0007172) | 2.73236760 |
| 24 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71730244 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.66361586 |
| 26 | protein targeting to plasma membrane (GO:0072661) | 2.65985959 |
| 27 | protein retention in ER lumen (GO:0006621) | 2.64842845 |
| 28 | adenosine receptor signaling pathway (GO:0001973) | 2.64252040 |
| 29 | membrane budding (GO:0006900) | 2.63531951 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63491165 |
| 31 | plasma membrane repair (GO:0001778) | 2.62675623 |
| 32 | glycine transport (GO:0015816) | 2.62403802 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 2.62249090 |
| 34 | cell migration in hindbrain (GO:0021535) | 2.62052151 |
| 35 | positive regulation of synapse maturation (GO:0090129) | 2.57264923 |
| 36 | cellular response to pH (GO:0071467) | 2.55537585 |
| 37 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.54939195 |
| 38 | response to nerve growth factor (GO:1990089) | 2.54939195 |
| 39 | stress fiber assembly (GO:0043149) | 2.54568633 |
| 40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.53129448 |
| 41 | renal filtration (GO:0097205) | 2.52940347 |
| 42 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51337473 |
| 43 | L-amino acid import (GO:0043092) | 2.50716553 |
| 44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.49761430 |
| 45 | membrane repolarization during action potential (GO:0086011) | 2.48996765 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.48150726 |
| 47 | amino acid import (GO:0043090) | 2.47543828 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 2.47227673 |
| 49 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.47066419 |
| 50 | activation of protein kinase A activity (GO:0034199) | 2.46212452 |
| 51 | axon cargo transport (GO:0008088) | 2.46184130 |
| 52 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.45320720 |
| 53 | nerve growth factor signaling pathway (GO:0038180) | 2.44230254 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 2.41195316 |
| 55 | * peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.39986863 |
| 56 | hemidesmosome assembly (GO:0031581) | 2.39714558 |
| 57 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.39228700 |
| 58 | glutamate secretion (GO:0014047) | 2.38420480 |
| 59 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.37019961 |
| 60 | neuronal action potential propagation (GO:0019227) | 2.36227631 |
| 61 | response to lipoprotein particle (GO:0055094) | 2.35957030 |
| 62 | neuronal action potential (GO:0019228) | 2.35751114 |
| 63 | glomerular filtration (GO:0003094) | 2.35218242 |
| 64 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.35057016 |
| 65 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.34807622 |
| 66 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.34661301 |
| 67 | regulation of ARF GTPase activity (GO:0032312) | 2.34230453 |
| 68 | positive regulation of protein dephosphorylation (GO:0035307) | 2.32706075 |
| 69 | myelin maintenance (GO:0043217) | 2.31820573 |
| 70 | adhesion of symbiont to host (GO:0044406) | 2.30679429 |
| 71 | potassium ion import (GO:0010107) | 2.29176591 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 2.28777291 |
| 73 | virion attachment to host cell (GO:0019062) | 2.28777291 |
| 74 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.27715950 |
| 75 | barbed-end actin filament capping (GO:0051016) | 2.26618137 |
| 76 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.25788032 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.24883117 |
| 78 | focal adhesion assembly (GO:0048041) | 2.24828543 |
| 79 | cell-substrate adherens junction assembly (GO:0007045) | 2.24828543 |
| 80 | cell communication by electrical coupling (GO:0010644) | 2.24766441 |
| 81 | positive regulation of pseudopodium assembly (GO:0031274) | 2.24463471 |
| 82 | potassium ion homeostasis (GO:0055075) | 2.23768253 |
| 83 | angiotensin maturation (GO:0002003) | 2.23627896 |
| 84 | mannose metabolic process (GO:0006013) | 2.22175895 |
| 85 | artery development (GO:0060840) | 2.21795884 |
| 86 | locomotory exploration behavior (GO:0035641) | 2.21393489 |
| 87 | mating behavior (GO:0007617) | 2.21179828 |
| 88 | adherens junction assembly (GO:0034333) | 2.19347293 |
| 89 | negative regulation of protein polymerization (GO:0032272) | 2.18763998 |
| 90 | regulation of guanylate cyclase activity (GO:0031282) | 2.18174587 |
| 91 | enteric nervous system development (GO:0048484) | 2.17561157 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16912502 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16912502 |
| 94 | modulation by symbiont of host immune response (GO:0052553) | 2.16912502 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16912502 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 2.16912502 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16912502 |
| 98 | regulation of regulated secretory pathway (GO:1903305) | 2.16781394 |
| 99 | neuronal ion channel clustering (GO:0045161) | 2.15991948 |
| 100 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.15690268 |
| 101 | regulation of ARF protein signal transduction (GO:0032012) | 2.15033633 |
| 102 | semaphorin-plexin signaling pathway (GO:0071526) | 2.14756792 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.14589231 |
| 104 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.13307404 |
| 105 | sexual reproduction (GO:0019953) | 2.13143855 |
| 106 | cellular sodium ion homeostasis (GO:0006883) | 2.12703605 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.12637962 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.12471518 |
| 109 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.11827525 |
| 110 | dopamine receptor signaling pathway (GO:0007212) | 2.11499862 |
| 111 | surfactant homeostasis (GO:0043129) | 2.11430692 |
| 112 | regulation of water loss via skin (GO:0033561) | 2.11026471 |
| 113 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.10627124 |
| 114 | sperm capacitation (GO:0048240) | 2.10514182 |
| 115 | actin filament capping (GO:0051693) | 2.10052281 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.09539779 |
| 117 | negative regulation of actin filament polymerization (GO:0030837) | 2.09486736 |
| 118 | negative regulation of cell killing (GO:0031342) | 2.08040515 |
| 119 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.08040515 |
| 120 | L-serine transport (GO:0015825) | 2.07523633 |
| 121 | response to acidic pH (GO:0010447) | 2.07437508 |
| 122 | cerebellar granule cell differentiation (GO:0021707) | 2.06873524 |
| 123 | neurotransmitter secretion (GO:0007269) | 2.06843960 |
| 124 | vesicle transport along microtubule (GO:0047496) | 2.06689281 |
| 125 | regulation of synaptic vesicle transport (GO:1902803) | 2.06627611 |
| 126 | regulation of leukocyte degranulation (GO:0043300) | 2.06582054 |
| 127 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.05980087 |
| 128 | response to water (GO:0009415) | 2.05709458 |
| 129 | positive regulation of receptor recycling (GO:0001921) | 2.05450299 |
| 130 | protein maturation by protein folding (GO:0022417) | 2.05278159 |
| 131 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.03566513 |
| 132 | cell-cell junction maintenance (GO:0045217) | 2.02373632 |
| 133 | sodium ion transmembrane transport (GO:0035725) | 2.02074489 |
| 134 | regulation of synapse maturation (GO:0090128) | 2.01821263 |
| 135 | establishment of protein localization to plasma membrane (GO:0090002) | 2.01307400 |
| 136 | cellular response to nicotine (GO:0071316) | 2.00836171 |
| 137 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.00427169 |
| 138 | dendritic spine organization (GO:0097061) | 1.99804312 |
| 139 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 1.99557790 |
| 140 | intermediate filament organization (GO:0045109) | 1.98951079 |
| 141 | positive regulation of Rap GTPase activity (GO:0032854) | 1.98579208 |
| 142 | receptor catabolic process (GO:0032801) | 1.98424991 |
| 143 | * regulation of early endosome to late endosome transport (GO:2000641) | 1.97764437 |
| 144 | negative regulation of cation channel activity (GO:2001258) | 1.97340857 |
| 145 | negative regulation of leukocyte chemotaxis (GO:0002689) | 1.97071411 |
| 146 | regulation of protein dephosphorylation (GO:0035304) | 1.96824661 |
| 147 | membrane tubulation (GO:0097320) | 1.96647116 |
| 148 | negative regulation of dendrite morphogenesis (GO:0050774) | 1.96447167 |
| 149 | regulation of synapse structural plasticity (GO:0051823) | 1.95970131 |
| 150 | potassium ion export (GO:0071435) | 1.95879063 |
| 151 | renal system process involved in regulation of blood volume (GO:0001977) | 1.95317647 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.95248807 |
| 153 | alanine transport (GO:0032328) | 1.94855371 |
| 154 | sodium ion homeostasis (GO:0055078) | 1.94651315 |
| 155 | neuromuscular process controlling balance (GO:0050885) | 1.93813669 |
| 156 | positive regulation of regulated secretory pathway (GO:1903307) | 1.93314451 |
| 157 | regulation of beta-amyloid formation (GO:1902003) | 1.93169995 |
| 158 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 1.92834360 |
| 159 | hypotonic response (GO:0006971) | 1.91800965 |
| 160 | negative regulation of ion transmembrane transport (GO:0034766) | 1.91272828 |
| 161 | negative regulation of GTP catabolic process (GO:0033125) | 1.91202786 |
| 162 | negative regulation of GTPase activity (GO:0034260) | 1.91202786 |
| 163 | regulation of actin filament depolymerization (GO:0030834) | 1.90880131 |
| 164 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.90761813 |
| 165 | peripheral nervous system neuron development (GO:0048935) | 1.90651027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.66948760 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49141842 |
| 3 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.20459699 |
| 4 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.01643054 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88589663 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87371317 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86480956 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85171116 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83994401 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81697891 |
| 11 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77653169 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73679928 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70973496 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70973496 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.69989971 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68470299 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 1.63991179 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63196844 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61366002 |
| 20 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.60825747 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60699641 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59656133 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58065872 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57999055 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.55082722 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54470875 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54240081 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53400945 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51718026 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49478351 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48277558 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48205355 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45252086 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45052866 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42774770 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40434656 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39365928 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38696812 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38365527 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37187710 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34735078 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34595480 |
| 43 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34578878 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33277907 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32798343 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31507276 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29452712 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28967648 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28509597 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27209105 |
| 51 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25334760 |
| 52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24874382 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24689688 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23772479 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.23264479 |
| 56 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22646598 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21989549 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21846824 |
| 59 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21400718 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20582979 |
| 61 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20289649 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20072003 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19921340 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19897514 |
| 65 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19493583 |
| 66 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19014650 |
| 67 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18634216 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18533649 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18128385 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17246893 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16535772 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.16271714 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14931558 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14640938 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14502502 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14480270 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14142713 |
| 78 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13989181 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13749551 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13281091 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11976129 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11791872 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11545009 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11026933 |
| 85 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10152411 |
| 86 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10148839 |
| 87 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09252260 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09212512 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09195963 |
| 90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08801576 |
| 91 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08641750 |
| 92 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08285860 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07603444 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06874499 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06405952 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05623005 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05612327 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05158934 |
| 99 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.03090698 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02565360 |
| 101 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02547262 |
| 102 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02453754 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02257320 |
| 104 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02036535 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01328806 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99969698 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99503039 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99020015 |
| 109 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.98812939 |
| 110 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98512150 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98450502 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98382625 |
| 113 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97921105 |
| 114 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97669556 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97549076 |
| 116 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97152597 |
| 117 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96799591 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96375585 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96354889 |
| 120 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96336427 |
| 121 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96065246 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95018972 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94899471 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94714297 |
| 125 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.94382435 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93816363 |
| 127 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93751766 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92683690 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91070134 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90429784 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89736872 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89364062 |
| 133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88597733 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88546181 |
| 135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88191677 |
| 136 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87794658 |
| 137 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86589915 |
| 138 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86581989 |
| 139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85519918 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85362530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004858_abnormal_nervous_system | 3.90656982 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.53484058 |
| 3 | MP0004270_analgesia | 3.47067472 |
| 4 | MP0002735_abnormal_chemical_nociception | 3.36024355 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.14218730 |
| 6 | MP0002733_abnormal_thermal_nociception | 3.09187187 |
| 7 | MP0002736_abnormal_nociception_after | 2.93257679 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.90796644 |
| 9 | MP0005409_darkened_coat_color | 2.89817704 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.85546232 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.76446223 |
| 12 | MP0001970_abnormal_pain_threshold | 2.60993606 |
| 13 | MP0002822_catalepsy | 2.52765452 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.50852673 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.47640438 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.41857413 |
| 17 | MP0003283_abnormal_digestive_organ | 2.21948203 |
| 18 | MP0005360_urolithiasis | 2.06013048 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.99615662 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.93516094 |
| 21 | MP0003329_amyloid_beta_deposits | 1.91803617 |
| 22 | MP0003303_peritoneal_inflammation | 1.84815578 |
| 23 | MP0004381_abnormal_hair_follicle | 1.81120274 |
| 24 | MP0001986_abnormal_taste_sensitivity | 1.79623380 |
| 25 | MP0010386_abnormal_urinary_bladder | 1.79530551 |
| 26 | MP0000920_abnormal_myelination | 1.77087135 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.76667610 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.69344120 |
| 29 | MP0003436_decreased_susceptibility_to | 1.67905563 |
| 30 | MP0000467_abnormal_esophagus_morphology | 1.63771524 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.59163232 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.55564424 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.49852961 |
| 34 | MP0005451_abnormal_body_composition | 1.48937159 |
| 35 | * MP0003635_abnormal_synaptic_transmissio | 1.46698935 |
| 36 | MP0002098_abnormal_vibrissa_morphology | 1.45057481 |
| 37 | MP0004510_myositis | 1.44801248 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.40063151 |
| 39 | MP0005670_abnormal_white_adipose | 1.39250842 |
| 40 | MP0003045_fibrosis | 1.39197830 |
| 41 | MP0003075_altered_response_to | 1.39148101 |
| 42 | MP0002060_abnormal_skin_morphology | 1.37733454 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.35783904 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.32228171 |
| 45 | MP0003634_abnormal_glial_cell | 1.31448306 |
| 46 | MP0000604_amyloidosis | 1.30024308 |
| 47 | MP0003724_increased_susceptibility_to | 1.29285847 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.26687414 |
| 49 | MP0002249_abnormal_larynx_morphology | 1.26225302 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.25902668 |
| 51 | MP0003690_abnormal_glial_cell | 1.25358662 |
| 52 | MP0002272_abnormal_nervous_system | 1.24172263 |
| 53 | MP0001958_emphysema | 1.23074752 |
| 54 | MP0005423_abnormal_somatic_nervous | 1.22929508 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.22680829 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.22229250 |
| 57 | MP0002064_seizures | 1.18184038 |
| 58 | MP0003633_abnormal_nervous_system | 1.18092670 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.16248119 |
| 60 | MP0000462_abnormal_digestive_system | 1.14029581 |
| 61 | MP0005275_abnormal_skin_tensile | 1.13807468 |
| 62 | MP0002796_impaired_skin_barrier | 1.11336824 |
| 63 | MP0001849_ear_inflammation | 1.11141398 |
| 64 | MP0000762_abnormal_tongue_morphology | 1.07101337 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.06568716 |
| 66 | MP0005023_abnormal_wound_healing | 1.06191207 |
| 67 | MP0001664_abnormal_digestion | 1.05081834 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.03807115 |
| 69 | MP0004272_abnormal_basement_membrane | 1.03239620 |
| 70 | MP0000534_abnormal_ureter_morphology | 1.02659287 |
| 71 | MP0001216_abnormal_epidermal_layer | 1.02091683 |
| 72 | MP0002653_abnormal_ependyma_morphology | 0.99763793 |
| 73 | MP0003279_aneurysm | 0.99317790 |
| 74 | MP0000566_synostosis | 0.99143150 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.98701887 |
| 76 | MP0000538_abnormal_urinary_bladder | 0.98591909 |
| 77 | MP0003866_abnormal_defecation | 0.97992518 |
| 78 | MP0005501_abnormal_skin_physiology | 0.97984661 |
| 79 | MP0008874_decreased_physiological_sensi | 0.96957379 |
| 80 | MP0005083_abnormal_biliary_tract | 0.96548859 |
| 81 | MP0000955_abnormal_spinal_cord | 0.95646248 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.95453450 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.95429670 |
| 84 | MP0003878_abnormal_ear_physiology | 0.95379330 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 0.95379330 |
| 86 | MP0000751_myopathy | 0.95173120 |
| 87 | MP0009840_abnormal_foam_cell | 0.94534380 |
| 88 | MP0004885_abnormal_endolymph | 0.94153008 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.92617168 |
| 90 | MP0003880_abnormal_central_pattern | 0.92463268 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.92200200 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.91524675 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.91387569 |
| 94 | MP0005166_decreased_susceptibility_to | 0.90835410 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.90300453 |
| 96 | MP0005410_abnormal_fertilization | 0.89403954 |
| 97 | MP0001756_abnormal_urination | 0.89186353 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.87851348 |
| 99 | * MP0002063_abnormal_learning/memory/cond | 0.87606373 |
| 100 | MP0003091_abnormal_cell_migration | 0.86532042 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 0.86519628 |
| 102 | MP0000747_muscle_weakness | 0.86231129 |
| 103 | MP0002184_abnormal_innervation | 0.86065791 |
| 104 | MP0001663_abnormal_digestive_system | 0.84844243 |
| 105 | MP0001440_abnormal_grooming_behavior | 0.84231041 |
| 106 | MP0009745_abnormal_behavioral_response | 0.83443677 |
| 107 | MP0008569_lethality_at_weaning | 0.83177846 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.82282597 |
| 109 | MP0000681_abnormal_thyroid_gland | 0.81722356 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.81609774 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.80461679 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.80447707 |
| 113 | MP0003631_nervous_system_phenotype | 0.80009213 |
| 114 | MP0008004_abnormal_stomach_pH | 0.78888964 |
| 115 | MP0005025_abnormal_response_to | 0.78764953 |
| 116 | MP0008260_abnormal_autophagy | 0.77824509 |
| 117 | MP0004947_skin_inflammation | 0.76678280 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 0.76374143 |
| 119 | MP0001270_distended_abdomen | 0.76352541 |
| 120 | MP0004043_abnormal_pH_regulation | 0.75670639 |
| 121 | MP0009931_abnormal_skin_appearance | 0.75478186 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.74331436 |
| 123 | MP0001486_abnormal_startle_reflex | 0.73206251 |
| 124 | MP0005390_skeleton_phenotype | 0.73082508 |
| 125 | MP0010771_integument_phenotype | 0.73062034 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.72633851 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.71999233 |
| 128 | MP0004130_abnormal_muscle_cell | 0.71572699 |
| 129 | MP0002229_neurodegeneration | 0.71548371 |
| 130 | MP0009046_muscle_twitch | 0.70262619 |
| 131 | MP0003879_abnormal_hair_cell | 0.69431188 |
| 132 | MP0000377_abnormal_hair_follicle | 0.68701416 |
| 133 | MP0005310_abnormal_salivary_gland | 0.68303320 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.67276385 |
| 135 | MP0000579_abnormal_nail_morphology | 0.65437915 |
| 136 | MP0002751_abnormal_autonomic_nervous | 0.65349785 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.64007816 |
| 138 | MP0002998_abnormal_bone_remodeling | 0.63788741 |
| 139 | MP0001501_abnormal_sleep_pattern | 0.63431303 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.63135583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.83740656 |
| 2 | Milia (HP:0001056) | 4.75005996 |
| 3 | Fragile nails (HP:0001808) | 4.71222957 |
| 4 | Ulnar claw (HP:0001178) | 4.68270768 |
| 5 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.37574405 |
| 6 | Onycholysis (HP:0001806) | 4.36237911 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.16835165 |
| 8 | Action tremor (HP:0002345) | 3.91393676 |
| 9 | Termporal pattern (HP:0011008) | 3.73149251 |
| 10 | Insidious onset (HP:0003587) | 3.73149251 |
| 11 | Abnormality of nail color (HP:0100643) | 3.61226949 |
| 12 | Plantar hyperkeratosis (HP:0007556) | 3.55226588 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.17009635 |
| 14 | Axonal loss (HP:0003447) | 3.07159899 |
| 15 | Peripheral hypomyelination (HP:0007182) | 3.05151955 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.97038178 |
| 17 | Onion bulb formation (HP:0003383) | 2.93389743 |
| 18 | Ankle clonus (HP:0011448) | 2.83976534 |
| 19 | Amelogenesis imperfecta (HP:0000705) | 2.78863594 |
| 20 | Pheochromocytoma (HP:0002666) | 2.77863693 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 2.76742179 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.75935265 |
| 23 | Hypercortisolism (HP:0001578) | 2.74401035 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 2.71644358 |
| 25 | Fragile skin (HP:0001030) | 2.70229122 |
| 26 | Abnormal blistering of the skin (HP:0008066) | 2.68975644 |
| 27 | Obstructive sleep apnea (HP:0002870) | 2.67658867 |
| 28 | Hammertoe (HP:0001765) | 2.66063596 |
| 29 | Diplopia (HP:0000651) | 2.65907139 |
| 30 | Abnormality of binocular vision (HP:0011514) | 2.65907139 |
| 31 | Nail dystrophy (HP:0008404) | 2.64415280 |
| 32 | Foot dorsiflexor weakness (HP:0009027) | 2.62001047 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 2.59669680 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.57479445 |
| 35 | Alopecia of scalp (HP:0002293) | 2.54971376 |
| 36 | Postural tremor (HP:0002174) | 2.52415966 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.49657543 |
| 38 | Ventricular fibrillation (HP:0001663) | 2.48395878 |
| 39 | Rapidly progressive (HP:0003678) | 2.48086897 |
| 40 | Pili torti (HP:0003777) | 2.45637390 |
| 41 | Hyperparathyroidism (HP:0000843) | 2.45445030 |
| 42 | Right ventricular cardiomyopathy (HP:0011663) | 2.37908742 |
| 43 | Increased CSF protein (HP:0002922) | 2.35082421 |
| 44 | Thick nail (HP:0001805) | 2.33250752 |
| 45 | Upper limb amyotrophy (HP:0009129) | 2.32684965 |
| 46 | Distal upper limb amyotrophy (HP:0007149) | 2.32684965 |
| 47 | Papilledema (HP:0001085) | 2.31850688 |
| 48 | Abnormality of the foot musculature (HP:0001436) | 2.27036450 |
| 49 | Hyporeflexia of lower limbs (HP:0002600) | 2.26752469 |
| 50 | Oligomenorrhea (HP:0000876) | 2.26374129 |
| 51 | Peripheral demyelination (HP:0011096) | 2.24806478 |
| 52 | Hypoplasia of dental enamel (HP:0006297) | 2.22383360 |
| 53 | Neuroendocrine neoplasm (HP:0100634) | 2.22302824 |
| 54 | Amyloidosis (HP:0011034) | 2.22037087 |
| 55 | Abnormality of the vocal cords (HP:0008777) | 2.21935528 |
| 56 | Cervical subluxation (HP:0003308) | 2.21175195 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.20309778 |
| 58 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.19784382 |
| 59 | Ridged nail (HP:0001807) | 2.14778241 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11367252 |
| 61 | Cholecystitis (HP:0001082) | 2.10758931 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.10758931 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.09222343 |
| 64 | Visual hallucinations (HP:0002367) | 2.08268721 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.05848843 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05848843 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.05415593 |
| 68 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.05289841 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.04462279 |
| 70 | Hypoventilation (HP:0002791) | 2.03434755 |
| 71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01980215 |
| 72 | Myotonia (HP:0002486) | 2.00437847 |
| 73 | Distal sensory impairment (HP:0002936) | 1.99938686 |
| 74 | Thin bony cortex (HP:0002753) | 1.99716668 |
| 75 | Apathy (HP:0000741) | 1.99132744 |
| 76 | Decreased motor nerve conduction velocity (HP:0003431) | 1.98305466 |
| 77 | Flat acetabular roof (HP:0003180) | 1.97547872 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 1.95647717 |
| 79 | Failure to thrive in infancy (HP:0001531) | 1.93862964 |
| 80 | Hyperacusis (HP:0010780) | 1.93745144 |
| 81 | Adrenal overactivity (HP:0002717) | 1.92342778 |
| 82 | Steppage gait (HP:0003376) | 1.92106096 |
| 83 | Vascular tortuosity (HP:0004948) | 1.89975751 |
| 84 | Vertebral compression fractures (HP:0002953) | 1.89939963 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88777127 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88777127 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88777127 |
| 88 | Thoracolumbar scoliosis (HP:0002944) | 1.88455845 |
| 89 | Insomnia (HP:0100785) | 1.88167525 |
| 90 | Broad metatarsal (HP:0001783) | 1.86843907 |
| 91 | Mutism (HP:0002300) | 1.86397175 |
| 92 | Abnormal hair laboratory examination (HP:0003328) | 1.86384271 |
| 93 | Abnormality of the corticospinal tract (HP:0002492) | 1.86220931 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 1.84947838 |
| 95 | Hyperactive renin-angiotensin system (HP:0000841) | 1.84317935 |
| 96 | Megalencephaly (HP:0001355) | 1.83684598 |
| 97 | Arterial tortuosity (HP:0005116) | 1.83554156 |
| 98 | Polygenic inheritance (HP:0010982) | 1.83397372 |
| 99 | Retinal atrophy (HP:0001105) | 1.82641255 |
| 100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81590584 |
| 101 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79844438 |
| 102 | Eczematoid dermatitis (HP:0000976) | 1.79785211 |
| 103 | Torticollis (HP:0000473) | 1.79458874 |
| 104 | Broad face (HP:0000283) | 1.79379302 |
| 105 | Abnormality of glycolipid metabolism (HP:0010969) | 1.78972210 |
| 106 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.78972210 |
| 107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.78972210 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 1.78537701 |
| 109 | Acanthosis nigricans (HP:0000956) | 1.77705626 |
| 110 | Flattened epiphyses (HP:0003071) | 1.76881799 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.76836693 |
| 112 | Potter facies (HP:0002009) | 1.76354515 |
| 113 | Facial shape deformation (HP:0011334) | 1.76354515 |
| 114 | Diminished motivation (HP:0000745) | 1.75727923 |
| 115 | Bronchomalacia (HP:0002780) | 1.75315097 |
| 116 | Malnutrition (HP:0004395) | 1.75107685 |
| 117 | Postural instability (HP:0002172) | 1.74603685 |
| 118 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73941253 |
| 119 | Systemic lupus erythematosus (HP:0002725) | 1.73617647 |
| 120 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73442040 |
| 121 | Dysautonomia (HP:0002459) | 1.73193945 |
| 122 | Shallow orbits (HP:0000586) | 1.72969302 |
| 123 | Loss of speech (HP:0002371) | 1.72883380 |
| 124 | Achilles tendon contracture (HP:0001771) | 1.72848137 |
| 125 | Stridor (HP:0010307) | 1.72104118 |
| 126 | Buphthalmos (HP:0000557) | 1.71984065 |
| 127 | Congenital glaucoma (HP:0001087) | 1.70567087 |
| 128 | Hypotrichosis (HP:0001006) | 1.69721980 |
| 129 | Focal seizures (HP:0007359) | 1.68640672 |
| 130 | Pterygium (HP:0001059) | 1.67428445 |
| 131 | Bundle branch block (HP:0011710) | 1.67061841 |
| 132 | Increased IgE level (HP:0003212) | 1.66834850 |
| 133 | Gingivitis (HP:0000230) | 1.66326099 |
| 134 | Impaired pain sensation (HP:0007328) | 1.66190199 |
| 135 | Abnormality of pain sensation (HP:0010832) | 1.66190199 |
| 136 | Depression (HP:0000716) | 1.65271295 |
| 137 | Limb dystonia (HP:0002451) | 1.65030455 |
| 138 | Coxa vara (HP:0002812) | 1.64819595 |
| 139 | Peritonitis (HP:0002586) | 1.62832880 |
| 140 | Emphysema (HP:0002097) | 1.61523079 |
| 141 | Striae distensae (HP:0001065) | 1.61393817 |
| 142 | Rigidity (HP:0002063) | 1.61312962 |
| 143 | Atrophic scars (HP:0001075) | 1.61111356 |
| 144 | Curly hair (HP:0002212) | 1.61079019 |
| 145 | Pyloric stenosis (HP:0002021) | 1.60993740 |
| 146 | Annular pancreas (HP:0001734) | 1.60658298 |
| 147 | Focal motor seizures (HP:0011153) | 1.60163926 |
| 148 | Premature rupture of membranes (HP:0001788) | 1.58610256 |
| 149 | Growth hormone excess (HP:0000845) | 1.58152136 |
| 150 | Nasal polyposis (HP:0100582) | 1.58033146 |
| 151 | Bladder diverticulum (HP:0000015) | 1.57435824 |
| 152 | Dementia (HP:0000726) | 1.57410404 |
| 153 | Polycythemia (HP:0001901) | 1.57122267 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.57098701 |
| 155 | Hydroxyprolinuria (HP:0003080) | 1.57007719 |
| 156 | Abnormality of proline metabolism (HP:0010907) | 1.57007719 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.56802772 |
| 158 | J-shaped sella turcica (HP:0002680) | 1.56691930 |
| 159 | Dysmetria (HP:0001310) | 1.56597669 |
| 160 | Widely patent fontanelles and sutures (HP:0004492) | 1.52893670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.44296225 |
| 2 | MAP3K9 | 3.16695510 |
| 3 | NTRK1 | 3.07536416 |
| 4 | SIK1 | 2.99725021 |
| 5 | PRPF4B | 2.72682114 |
| 6 | LIMK1 | 2.61355147 |
| 7 | LMTK2 | 2.58282356 |
| 8 | TRIB3 | 2.57322461 |
| 9 | MET | 2.56052290 |
| 10 | PRKD3 | 2.44687258 |
| 11 | EPHB1 | 2.41544319 |
| 12 | PIK3CA | 2.34626654 |
| 13 | TESK1 | 1.94352268 |
| 14 | RIPK1 | 1.77322587 |
| 15 | EPHA4 | 1.76920219 |
| 16 | ARAF | 1.75446612 |
| 17 | SMG1 | 1.75169672 |
| 18 | GRK5 | 1.71231422 |
| 19 | STK38 | 1.67745625 |
| 20 | WNK4 | 1.63629945 |
| 21 | PAK6 | 1.62041926 |
| 22 | RIPK4 | 1.56310961 |
| 23 | ERN1 | 1.51371850 |
| 24 | STK39 | 1.45670894 |
| 25 | NTRK3 | 1.45619074 |
| 26 | LATS2 | 1.42650537 |
| 27 | GRK6 | 1.42014435 |
| 28 | MINK1 | 1.40205071 |
| 29 | WNK1 | 1.39162369 |
| 30 | EPHB2 | 1.38277103 |
| 31 | MATK | 1.34518153 |
| 32 | PTK2B | 1.34223078 |
| 33 | PTK2 | 1.32775037 |
| 34 | * KSR2 | 1.23680707 |
| 35 | TAOK1 | 1.22011611 |
| 36 | PKN2 | 1.21613507 |
| 37 | DAPK2 | 1.20641680 |
| 38 | FER | 1.19724630 |
| 39 | TAOK3 | 1.18285235 |
| 40 | PRKD2 | 1.17577613 |
| 41 | LRRK2 | 1.11743616 |
| 42 | PRKG2 | 1.11107136 |
| 43 | CAMKK1 | 1.10702494 |
| 44 | EPHA2 | 1.09978765 |
| 45 | FGFR4 | 1.08435046 |
| 46 | PTK6 | 1.08100186 |
| 47 | BMX | 1.03355314 |
| 48 | * RET | 1.03127141 |
| 49 | TNK2 | 1.02488628 |
| 50 | SIK2 | 1.01563062 |
| 51 | MAP3K3 | 0.99978241 |
| 52 | EPHA3 | 0.99964354 |
| 53 | RPS6KA2 | 0.95135575 |
| 54 | MAP4K1 | 0.94140167 |
| 55 | * MAP2K1 | 0.92766866 |
| 56 | MAPKAPK5 | 0.91403858 |
| 57 | * MAP3K1 | 0.89306172 |
| 58 | FRK | 0.89276481 |
| 59 | UHMK1 | 0.88740657 |
| 60 | MAP3K12 | 0.87248070 |
| 61 | MAP2K3 | 0.87110559 |
| 62 | PRKCH | 0.86724266 |
| 63 | PDPK1 | 0.85958471 |
| 64 | PHKG1 | 0.85297276 |
| 65 | PHKG2 | 0.85297276 |
| 66 | DMPK | 0.84539075 |
| 67 | PDGFRA | 0.83563482 |
| 68 | TAOK2 | 0.83466628 |
| 69 | TESK2 | 0.82808979 |
| 70 | IRAK4 | 0.82246141 |
| 71 | MAPK12 | 0.81633869 |
| 72 | CDK5 | 0.81257612 |
| 73 | NME1 | 0.79430172 |
| 74 | IRAK3 | 0.79152919 |
| 75 | TYK2 | 0.76898901 |
| 76 | SCYL2 | 0.75988592 |
| 77 | * MAP2K2 | 0.74550644 |
| 78 | PAK3 | 0.72155540 |
| 79 | DYRK1B | 0.70152989 |
| 80 | HIPK2 | 0.68836009 |
| 81 | CAMK2D | 0.68762673 |
| 82 | ZAP70 | 0.68521159 |
| 83 | ILK | 0.68221427 |
| 84 | CSK | 0.67734852 |
| 85 | PRKD1 | 0.67146226 |
| 86 | TIE1 | 0.67016108 |
| 87 | CDK14 | 0.64900481 |
| 88 | CDK12 | 0.63581668 |
| 89 | ROCK2 | 0.61199502 |
| 90 | DDR2 | 0.60329532 |
| 91 | ALK | 0.59872387 |
| 92 | SGK223 | 0.58883591 |
| 93 | SGK494 | 0.58883591 |
| 94 | MAP3K6 | 0.58056963 |
| 95 | DAPK3 | 0.56491116 |
| 96 | TYRO3 | 0.55630395 |
| 97 | ROCK1 | 0.54539399 |
| 98 | NEK6 | 0.54488393 |
| 99 | PDK1 | 0.54138622 |
| 100 | SRC | 0.53667470 |
| 101 | ICK | 0.53171396 |
| 102 | FYN | 0.53154078 |
| 103 | PRKCZ | 0.53024572 |
| 104 | TBK1 | 0.52293705 |
| 105 | LATS1 | 0.52053555 |
| 106 | EEF2K | 0.51382546 |
| 107 | BRAF | 0.50937372 |
| 108 | CSF1R | 0.50379255 |
| 109 | MAPKAPK3 | 0.50290734 |
| 110 | PDGFRB | 0.49544447 |
| 111 | STK11 | 0.49248460 |
| 112 | CAMK1 | 0.47933108 |
| 113 | SIK3 | 0.47847112 |
| 114 | CAMK2B | 0.47081863 |
| 115 | MAP2K4 | 0.46919628 |
| 116 | FGR | 0.45363352 |
| 117 | CDC42BPA | 0.45108088 |
| 118 | RPS6KL1 | 0.45031298 |
| 119 | RPS6KC1 | 0.45031298 |
| 120 | RPS6KA6 | 0.44166407 |
| 121 | CDK15 | 0.43854810 |
| 122 | MAP3K7 | 0.43850142 |
| 123 | PRKCE | 0.43525320 |
| 124 | MOS | 0.43385552 |
| 125 | MST4 | 0.43331828 |
| 126 | TGFBR2 | 0.42465797 |
| 127 | MARK2 | 0.42393478 |
| 128 | ADRBK1 | 0.41691835 |
| 129 | MAP3K11 | 0.41619684 |
| 130 | MAP3K4 | 0.41164344 |
| 131 | SGK3 | 0.40876645 |
| 132 | PAK4 | 0.40159377 |
| 133 | CDK18 | 0.39996706 |
| 134 | CAMK2G | 0.39926654 |
| 135 | MAPK7 | 0.39353284 |
| 136 | CAMK1G | 0.38338656 |
| 137 | MARK1 | 0.38023055 |
| 138 | ABL2 | 0.37735196 |
| 139 | HCK | 0.37607980 |
| 140 | CDK11A | 0.36103313 |
| 141 | TTN | 0.35047821 |
| 142 | MAP3K13 | 0.34786671 |
| 143 | FES | 0.33611865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.45014511 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27839620 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 2.14030667 |
| 4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.08979228 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.99767570 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.83988333 |
| 7 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.63946583 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.56069823 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 1.53223865 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52387100 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.49240861 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48447977 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.47509977 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36087715 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34232163 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33451837 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30821012 |
| 18 | Endocytosis_Homo sapiens_hsa04144 | 1.27798592 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26200037 |
| 20 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.18092858 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16496883 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.16055298 |
| 23 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13046503 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10848436 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10333665 |
| 26 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09946572 |
| 27 | Tight junction_Homo sapiens_hsa04530 | 1.06519021 |
| 28 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04954581 |
| 29 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04818430 |
| 30 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04208998 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02963986 |
| 32 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02862738 |
| 33 | * Salmonella infection_Homo sapiens_hsa05132 | 1.01381197 |
| 34 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01120133 |
| 35 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00254277 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00232508 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.00068537 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.00068109 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98831558 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 0.98690527 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98654618 |
| 42 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96889311 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93499180 |
| 44 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92842110 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91377692 |
| 46 | * Prion diseases_Homo sapiens_hsa05020 | 0.90992328 |
| 47 | * Glioma_Homo sapiens_hsa05214 | 0.90830180 |
| 48 | * Gap junction_Homo sapiens_hsa04540 | 0.90821404 |
| 49 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90593986 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89809200 |
| 51 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88687986 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87749256 |
| 53 | * Axon guidance_Homo sapiens_hsa04360 | 0.87701100 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87260539 |
| 55 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.85318181 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85301194 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84207214 |
| 58 | * Long-term potentiation_Homo sapiens_hsa04720 | 0.84099741 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83014335 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82337763 |
| 61 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82235608 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81713107 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81682845 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81025751 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80596776 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80238685 |
| 67 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78725406 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78079808 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77968474 |
| 70 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77184935 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76481748 |
| 72 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75452425 |
| 73 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73493712 |
| 74 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.72871853 |
| 75 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72732355 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72100815 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71849092 |
| 78 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70812845 |
| 79 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70512807 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69736469 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69151935 |
| 82 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68928799 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68321195 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.68212397 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67780466 |
| 86 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67621040 |
| 87 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67551693 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67373524 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67029182 |
| 90 | * Focal adhesion_Homo sapiens_hsa04510 | 0.66654280 |
| 91 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66256177 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65924833 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65664131 |
| 94 | * Long-term depression_Homo sapiens_hsa04730 | 0.65137860 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64029777 |
| 96 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.63356963 |
| 97 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.63195482 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.62959544 |
| 99 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62565238 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62365161 |
| 101 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62215851 |
| 102 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62157163 |
| 103 | * Tuberculosis_Homo sapiens_hsa05152 | 0.60693462 |
| 104 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59944643 |
| 105 | * Platelet activation_Homo sapiens_hsa04611 | 0.59850702 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59789299 |
| 107 | * Leishmaniasis_Homo sapiens_hsa05140 | 0.59691680 |
| 108 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.58980014 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58929368 |
| 110 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58859361 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58402315 |
| 112 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57739314 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57642563 |
| 114 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57561502 |
| 115 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57543741 |
| 116 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.57400675 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57256813 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57244788 |
| 119 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57160682 |
| 120 | * Pertussis_Homo sapiens_hsa05133 | 0.57094405 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56788260 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56377812 |
| 123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55261002 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55150672 |
| 125 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55132824 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54457915 |
| 127 | * Melanogenesis_Homo sapiens_hsa04916 | 0.54221449 |
| 128 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54146270 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.53622567 |
| 130 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53117040 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50928939 |

